No Data
No Data
No Data
No Data
No Data
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the full year and three months ended Dec. 31, 2023.Net revenue grew to CA$33 million ($24.3 mi
BenzingaMar 27 18:32 ET
Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
The following is a summary of the MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript:Financial Performance:MediPharm reported Q4 2023 revenue of $9.1 million, a 63% increase compared to the
moomoo AIMar 27 15:45 ET · Conference Call
MediPharm Labs Reports Q4 Results
Seeking AlphaMar 27 06:37 ET
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
06:33 AM EDT, 03/27/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
MT NewswiresMar 27 06:33 ET
Notable Earnings Before Wednesday's Open
Seeking AlphaMar 26 09:51 ET
MediPharm Labs Corp. Brief: Says "Historic Change Is a Significant Positive Step in Removing the Stigma Related to Medical Cannabis"
06:32 AM EDT, 03/25/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"
MT NewswiresMar 25 06:32 ET
No Data
No Data